Founding CEO Kyle Clark celebrates at the New York Stock Exchange as Beta Technologies launches its public offering. Photo courtesy of Brian Jenkins/BETA Technologies Theo Wells-Spackman is a Report ...

Shares of electric aviation startup Beta Technologies took flight Tuesday as the company made its debut on the New York Stock Exchange with an outsized raise of $1 billion and a stock price that ...

Nov 4 (Reuters) - Electric aircraft maker Beta Technologies (BETA.N), opens new tab was valued at $7.44 billion after its shares opened flat in their New York Stock Exchange debut on Tuesday, ...

[Stay on top of transportation news: Get TTNews in your inbox.] Beta Technologies, an electric-powered aircraft manufacturer, raised $1.02 billion in an upsized initial public offering, pricing above ...

In a change of pace, one company operating in the aerospace sector is expected to make its market debut today. Here’s what you need to know about Beta Technologies and its initial public offering: ...

Read Seven Days’ November 5, 2025, cover story on Beta here. Vermont electric aviation startup Beta Technologies raked in more than $1 billion on Tuesday as it debuted on the New York Stock Exchange ...

This summer, I got cultural whiplash. As a child of the ’90s and early 2000s, I grew up with my mother’s and grandmother’s generations’ fight for legal and workplace equality helping shed social ...

Theo Wells-Spackman is a Report for America corps member who reports for VTDigger.org. Updated at 3:44 p.m. BETA Technologies filed for an initial public offering on Monday morning, after reports of ...

The iOS 26 beta is out now! It’s tempting to rush out and download it. Now that you don’t even need a paid developer account to grab the Developer Beta, there’s nothing but a couple minutes of filling ...

They drink matcha lattes. They carry tote bags. And, in recent weeks, they've become an internet sensation. They're called "performative men" − and, even if you haven't heard of them yet, odds are you ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...